Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Interest Coverage Ratio (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Interest Coverage Ratio readings, the most recent being 9.36 for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio fell 312.53% year-over-year to 9.36, compared with a TTM value of 0.11 through Dec 2025, up 102.8%, and an annual FY2025 reading of 0.11, up 102.8% over the prior year.
  • Interest Coverage Ratio hit 9.36 in Q4 2025 for Apellis Pharmaceuticals, down from 19.79 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 37.96 in Q4 2022, with the low at 74.5 in Q4 2021.
  • Median Interest Coverage Ratio over the past 5 years was 13.26 (2022), compared with a mean of 15.71.
  • The sharpest move saw Interest Coverage Ratio tumbled 650.24% in 2021, then skyrocketed 624.49% in 2025.
  • Year by year, Interest Coverage Ratio stood at 74.5 in 2021, then soared by 150.95% to 37.96 in 2022, then crashed by 130.08% to 11.42 in 2023, then surged by 80.13% to 2.27 in 2024, then crashed by 312.53% to 9.36 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 9.36, 19.79, and 2.98 for Q4 2025, Q3 2025, and Q2 2025 respectively.